Home » Topics » HIV/AIDS, BioWorld Science

HIV/AIDS, BioWorld Science
RSS

Research Council of Norway grant supports Bionor's development of Vacc-4x for HIV

Jan. 30, 2017

ViiV Healthcare UK identifies novel HIV integrase inhibitors

Jan. 30, 2017

First-in-human data for 10-1074 in HIV-1-infected individuals

Jan. 26, 2017

ViiV Healthcare UK presents novel HIV integrase inhibitors

Jan. 24, 2017

GeoVax begins new study of HIV vaccine

Jan. 24, 2017

Full phase I data reported for novel anti-HIV compound ABX-464

Jan. 20, 2017

NIAID initiates phase I trial of VRC07-523LS

Jan. 19, 2017

GlaxoSmithKline describes new indoleamine 2,3-dioxygenase 1 inhibitors

Jan. 18, 2017

Kyorin Pharmaceutical prepares and tests FPR2 agonists

Dec. 19, 2016

Merck & Co. describes HIV integrase inhibitors

Dec. 16, 2016

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...